regulation tracker featured image x

Global Gene Editing Regulation Tracker

Our interactive GLP global map explains the status of each country’s regulations for human and agricultural gene editing and gene drives.
organic donor featured image x outlined

Anti-GMO Advocacy Funding Tracker

This GLP project maps contributions by foundations to anti-biotech activists and compares it to pro-GMO industry spending.
glp logo x minified

The firms putting a copyright on cancer

| | July 3, 2013
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The following is an edited excerpt.

Myriad Genetics has, for decades, been seen as the symbol of genomic greed. Ever since the Utah company patented the two major breast cancer genes, BRCA1 and BRCA2, in the Nineties, and a diagnostic test for them, it has defended those patents aggressively in a string of legal showdowns that have scared off companies trying to develop cheaper tests.

Not everyone, however, finds clarity or comfort in the judgment of the US Supreme Court on Association for Molecular Pathology v. Myriad Genetics.

Read the full story here: The firms putting a copyright on cancer

The GLP Needs Your Help
It is easier than ever for advocacy groups to spread disinformation on pressing science issues, such as the ongoing coronavirus pandemic. No, vaccines are not harmful. Yes, the use of biotechnology, GMOs or gene editing to develop antigens for treatments including vaccines are part of the solution. To inform the public about what’s really going on, we present the facts and challenge those who don't. We can’t do this work without your help. Please support us – a donation of as little as $10 a month helps support our vital myth-busting efforts.
DONATE
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend